Enovis Corporation

ENOV ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $36.4M $48.2M $36.2M $24.3M $680.3M $97.1M $109.6M $77.2M
Accounts Receivable $442.8M $407.0M $291.5M $267.4M $255.0M $517.0M $561.9M $386.6M
Inventory $584.4M $547.1M $468.8M $426.6M $356.2M $564.8M $571.6M $359.7M
Total Current Assets $1.21B $1.15B $896.5M $795.0M $2.30B $1.36B $1.40B $1.96B
Property, Plant & Equipment $507.1M $404.5M $270.8M $236.7M $235.1M $487.0M $491.2M $327.2M
Goodwill $718.3M $1.69B $2.06B $1.98B $1.93B $1.76B $3.20B $1.50B
Intangible Assets (Excl. Goodwill) $1.24B $1.32B $1.13B $1.11B $1.15B $1.66B $1.72B $628.3M
Total Assets $3.83B $4.72B $4.51B $4.27B $8.52B $7.35B $7.39B $6.62B
Liabilities
Accounts Payable $187.5M $179.1M $132.5M $135.6M $155.2M $330.3M $359.8M $291.2M
Total Current Liabilities $598.5M $529.0M $369.6M $565.2M $1.02B $811.7M $857.3M $1.20B
Long-Term Debt $1.26B $1.31B $466.2M $40.0M $2.08B $2.20B $2.28B $1.19B
Total Liabilities $2.34B $2.15B $1.09B $823.4M $3.85B $3.76B $3.90B $3.14B
Stockholders' Equity
Retained Earnings $-1.47B $-283.0M $542.5M $575.7M $589.0M $517.4M $479.6M $991.8M
Total Stockholders' Equity $1.49B $2.56B $3.42B $3.45B $4.62B $3.54B $3.44B $3.27B
← Newer Page 1 of 2 Older →